Serplulimab represents a exciting breakthrough in immunotherapy , acting as a novel Immune suppressor designed to inhibit the interaction between PD-L1 and its receptor . This process enables the https://adreabzzq577911.pointblog.net/serplulimab-a-promising-immune-blocker-for-tumour-management-93088696